Forbes: Gates Foundation CEO: A Picture Of Hope In Early Ebola Vaccine Trials
Sue Desmond-Hellmann, CEO of the Bill & Melinda Gates Foundation

“…Ebola surely won’t be the last crisis we face. Tackling today’s era of global challenges will require the enormous innovative capacity of business. It will require bold new partnerships, such as the one we saw with this Ebola vaccine [now undergoing clinical trials]. Above all, it will require a commitment to ensuring that all people — no matter where they were born or how much they can pay — have access to the life-saving medicines they need. … When we act quickly and generously — when we commit to doing whatever it takes to save lives — we can achieve beautiful results” (1/12).